Evidence map›Paper›PMID 24833678›Full record

SynthesisBMJ open2014

Comparative efficacy and safety of treatments for localised prostate cancer: an application of network meta-analysis.

Tengbin Xiong, Rebecca M Turner, Yinghui Wei, David E Neal, Georgios Lyratzopoulos, Julian P T Higgins

Abstract readComparative StudySystematic ReviewNetwork Meta-Analysis
In one paragraph

Synthesis in BMJ open, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Primary cryotherapy for localised or locally advanced prostate cancer.The Cochrane database of systematic reviews · 2018
    Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Review
  11. Review
  12. Reliability and validity of PROMIS measures administered by telephone interview in a longitudinal localized prostate cancer study.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2016
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tengbin XiongDepartment of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
Rebecca M TurnerMRC Biostatistics Unit, Institute of Public Health, Forvie Site, Cambridge, UK.
Yinghui WeiMRC Clinical Trials Unit, London Hub for Trials Methodology Research, London, UK School of Computing and Mathematics, Plymouth University, Plymouth, UK.
David E NealDepartment of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
Georgios LyratzopoulosDepartment of Public Health and Primary Care, Cambridge Centre for Health Services Research, University of Cambridge, Cambridge, UK.
Julian P T HigginsMRC Biostatistics Unit, Institute of Public Health, Forvie Site, Cambridge, UK Centre for Reviews and Dissemination, University of York, York, UK.

Funding

Department of Health PDF-2011-04-047Medical Research Council G0900871Medical Research Council MC_U105260558Medical Research Council MC_U105285807
6 · The paper itself

Abstract

contextThere is ongoing uncertainty about the optimal management of patients with localised prostate cancer.

objectiveTo evaluate the comparative efficacy and safety of different treatments for patients with localised prostate cancer.

designSystematic review with Bayesian network meta-analysis to estimate comparative ORs, and a score (0-100%) that, for a given outcome, reflects average rank order of superiority of each treatment compared against all others, using the Surface Under the Cumulative RAnking curve (SUCRA) statistic. DATA SOURCES: Electronic searches of MEDLINE without language restriction. STUDY SELECTION: Randomised trials comparing the efficacy and safety of different primary treatments (48 papers from 21 randomised trials included 7350 men). DATA EXTRACTION: 2 reviewers independently extracted data and assessed risk of bias.

resultsComparative efficacy and safety evidence was available for prostatectomy, external beam radiotherapy (different types and regimens), observational management and cryotherapy, but not high-intensity focused ultrasound. There was no evidence of superiority for any of the compared treatments in respect of all-cause mortality after 5 years. Cryotherapy was associated with less gastrointestinal and genitourinary toxicity than radiotherapy (SUCRA: 99% and 77% for gastrointestinal and genitourinary toxicity, respectively).

conclusionsThe limited available evidence suggests that different treatments may be optimal for different efficacy and safety outcomes. These findings highlight the importance of informed patient choice and shared decision-making about treatment modality and acceptable trade-offs between different outcomes. More trial evidence is required to reduce uncertainty. Network meta-analysis may be useful to optimise the power of evidence synthesis studies once data from new randomised controlled studies in this field are published in the future.

Indexed as

HumansMaleProstatic NeoplasmsRandomized Controlled Trials as TopicTherapeuticsTreatment OutcomeMeta-AnalysisProstate CancerRandomised TrialsSystematic ReviewTreatment

Identifiers

PMID24833678
PMCPMC4024605

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.